|
【参考文献】
1 Schultz RO, Van Horn DL, Peters MA, et al. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981;79:180199
2季迅达,朱皓皓,李洪,等.2型糖尿病角膜知觉减退及其与眼表异常的相关性研究.眼视光学杂志2007;9(2):9799
3 CreuzotGarcher C, Lafontaine PO, Gualino O, et al. Study of ocular surface involvement in diabetic patients. J Fr Ophthalmol 2005；28(6)：583588
4 Ben Osma N. The cornea of diabetics. J Fr Ophthalmol 1995;18:120
5 Liu XR, Wang W, Yuan JQ. Distribution and morphological changes of corneal nerves in type 2 diabetic patients detected by confocal microscopy. Chin Ophthalmol 2006;42(10):896899
6 Midena E, Brugin E, Ghirlando A, et al. Corneal diabetic neuropathy: a confocal microscopy study. Refract Surg2006;22(9 Suppl):10471052
7 Rosenberg ME, Tervo TM, Immonen IJ, et al. Corneal structure andsensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci2000;41:29152921
8李金瑛,麦才铿,胡燕华.实验性糖尿病兔角膜神经组织化学和超微结构观察.眼科研究1995;13(3):145146
9 Nielsen NV. Corneal sensitivity and vibratory perception in diabetes mellitus. Acta Ophthalmol (Copenh) 1978;56(3):406411
10 Nielsen NV, Lund FS. Diabetic polyneuropathy. Corneal sensitivity, vibratory perception and Achilles tendon reflex in diabetics. Acta Neurol Scand1979;59(1):1522
11 Yoon KC, Im SK, Seo MS. Changes of tear film and ocular surface in diabetes mellitus. Korean J Ophthalmol2004；18(2)：168174
12 Bosquet F, Grimaldi A. Role of the polyol pathway in the occurrence of degenerative complications of diabetes. Presse Med1986;15(19):879883
13 Xia P, Inoguchi T, Kern TS, et al. Characterization of the mechanism for the chronic activation of diacylglycerolprotein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43(9):11221129
14 Greene DA. The pathogenesis and prevention of diabetic neuropathy and nephropathy. Metabolisml988;37(2 Suppl 1):2529
15 Bravi MC, Pietrangeli P, Laurenti O, et al. Polyol pathway activation and glutathione redox status in noninsulindependent diabetic patients. Metabolism1997;46(10):11941198
16 Herse P, Petchell M. Oxygen consumption and ATPase activity in the corneal epithelium of rabbits with alloxan induced hyperglycemia. Acta Ophthalmol Scand1998;76 (5):528532
17 Juan CC, Khaldoun A, Liliana N. Transient expression of hypoxiainducible factor1 alpha and target genes in peripheral nerves from diabetic rats. Neurosci Lett 2005；374：179182
18 Song HP, Hui YN, Wang LL, et al. Expression of hypoxia inducible factor1a in the corneal epithelium cells of early stage diabetic rats. Int J Ophthalmol(Guoji Yanke Zazhi) 2006;6(2):352356
19 Lambiase A, Boninni S, Micem A, et al. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 1998;39：l2721275
20 Nilsson G,FombergNilsson K,Xiang Z, et al. Human mast cells express functional TrkA and are asource of nerve growth factor. Eur J Immunol 1997;27：22952301
21 You L, Kruse FE, Volcker HE. Neurotrophic factor in the human cornea. Invest Opthathmol Vis Sci2000;41(3)：692
22苏会璇.糖尿病神经病变的发病机制.临床神经病学杂志2003;16(5):314
23 Yue DK, Brooks B. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Med J 1993;157(5):7680
24 Troger J,Humpel C,Kremser B, et al. The effect of streptozotocininduced diabetes mellitus on substance P and calcitonin generelated peptide expression in the rat trigeminal ganglion. Brain Res 1999;842(1):8491
25 Watanabe M, Nakayasu K, Iwatsu M, et al. Endogenous substance P in corneal epithelial cells and keratocytes. Jpn J Ophthalmol2002;46(6):616620
26 Yue DK, Brooks B. The effect of diabetes on neuropeptide content in the rat cornea and iris. Invest Ophthalmol Vis Sci1995;36(6):11001106
27 Boschi A. Neuroophthalmological problems in the diabetic patient. Bull Soc Belge Ophtalmol. Review French 1995;256:145150
28 Hosotani H, Ohashi Y, Yamada M, et al. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor，CT112. Am J Ophthalmol 1995;119(3)：288289
29 Fujishima H, Shimazaki J, Yagi Y, et al. Improvement of corneal sensation and tear dynamics in diabeticpatients by oral aldose reductase inhibitor. ONO2235：a preliminary study. Cornea1996;15(4)：368375
30 Stead RH, Bienenstock J, Stansz AM. Neuropeptide regulation ofmucosal. Lmmunol Rev 1987；100：333359
31 Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998；338：11741180 上一页 [1] [2] [3] |
